Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Real-world experience of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma
PaperCitations, authors & open-access status
Real-world experience of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 64 citations, 2017 year and diamond oa status.
64
Citations
2017
Year
diamond
OA Status